Skip to main content

Advertisement

SpringerLink
Log in

Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To study the prevalence of anti-HCV antibodies among patients admitted to the rheumatology department, Cairo University hospitals, in 6-month period as well as to determine whether chronic HCV infection was the primary cause of their admission or just a concomitant association with the rheumatic disease. One hundred and fifty-seven patients were included in this study. They represent all patients admitted to the rheumatology inpatient department of Cairo University hospitals during the study period. Preset questionnaire including detailed demographic data, cause of admission and clinical manifestations of their disease was obtained for every patient. All patients were screened for HCV antibodies using ELISA technique. Other laboratory and imaging investigations were done according to the patient’s diagnosis. Twenty-nine patients (18.5%) were positive for HCV antibody. Eleven patients of them (38%) were admitted due to rheumatic manifestations directly related to chronic HCV infection, which represent 7% of all admitted patients (11/157). HCV antibodies were found in 17.6 and 6.7% among patients with rheumatoid and systemic lupus erythematosus. Arthritis, palpaple purpura, digital gangrene and mononeuritis multiplex were the most common causes of admission related to chronic HCV infection. HCV antibodies were found in 18.5% among admitted patients to the rheumatology ward. The rheumatic manifestations of chronic HCV represent the primary cause of admission in 7% of all admitted patients. HCV screening should be included in the routine investigations for patients presenting to rheumatology departments in countries with high prevalence of chronic HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rustgi VD (2007) The epidemiology of hepatitis C infection in the United States. J Gastroenterol 42:513–521

    Article  PubMed  Google Scholar 

  2. Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN et al (2002) Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 67(4):436–442

    PubMed  Google Scholar 

  3. Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43(5):915–922

    Article  PubMed  Google Scholar 

  4. Armstrong GL, Walsley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ (2006) The prevalence of hepatitis C virus infection in the United States, 199 through 2002. Ann Intern Med 144(10):705–714

    PubMed  Google Scholar 

  5. Shalaby S, Kabbash IA, El Saleet G, Mansour N, Omar A, El Nawawy A (2010) Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governerate, Egypt. East Mediterr Health J 16(1):10–17

    PubMed  CAS  Google Scholar 

  6. El-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A (1996) Response to interferon-a of Egyptian patients infected with hepatitis C virus genotype 4. J Viral Hepat 3:261–264

    Article  PubMed  CAS  Google Scholar 

  7. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W et al (1997) Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26(2):236–243

    Article  PubMed  CAS  Google Scholar 

  8. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698–707

    Article  PubMed  CAS  Google Scholar 

  9. Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J (2000) Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 32:172–174

    Article  PubMed  CAS  Google Scholar 

  10. McCarthy MC, El Tigani A, Khalid IO, Hyams KC (1994) Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Trans Roy Soc Top Med Hyg 88:534–536

    Article  CAS  Google Scholar 

  11. World Health Organization (WHO) (1997) Hepatis C global prevalence. Wkly Epidemiological Rec 72:341–344

    Google Scholar 

  12. Shobokshi O, Serebour E, Shakni L, Al Saffy Y, Ahdai M (1999) Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58(1):44–48

    Article  PubMed  CAS  Google Scholar 

  13. Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad S et al (1995) Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 283(2):239–244

    Article  PubMed  CAS  Google Scholar 

  14. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur R, Magder L et al (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355(9207):887–891

    Article  PubMed  CAS  Google Scholar 

  15. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, Abdel-Hamid M et al (2000) Hepatitis C in a community in upper Egypt: I. cross-sectional survey. Am J Trop Med Hyg 63(5–6):236–241

    PubMed  CAS  Google Scholar 

  16. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Madkour S et al (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33:248–253

    Article  PubMed  CAS  Google Scholar 

  17. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Medicine (Baltimore) 79(1):47–56

    Article  CAS  Google Scholar 

  18. Ramos-Casals M, Font J (2005) Extra-hepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 17(4):447–455

    PubMed  Google Scholar 

  19. Sterling RK, Bralow S (2006) Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 8(1):53–59

    Article  PubMed  Google Scholar 

  20. Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N et al (1998) Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum 28(2):107–113

    Article  PubMed  CAS  Google Scholar 

  21. Buskila D (2000) Hepatitis C-associated arthritis. Curr Opin Rheumatol 12(4):295–299

    Article  PubMed  CAS  Google Scholar 

  22. Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73(6):633–638

    Article  PubMed  Google Scholar 

  23. Buskila D (2009) Hepatitis C-associated rheumatic disorders. Rheum Dis Clin North Am 35(1):111–123

    Article  PubMed  Google Scholar 

  24. Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J et al (2005) Systemic autoimmune diseases coexisting with chronic hepatitis C virus infection (the HISPAMIC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257(6):549–557

    Article  PubMed  CAS  Google Scholar 

  25. Barbosa VS, da Silva NA, Martins RMB (2005) Hepatitis C virus seroprevelance and genotypes in patients with diffuse connective tissue diseases and spondyloarthopathies. Braz J Med Biol Res 38(5):801–805

    Article  PubMed  CAS  Google Scholar 

  26. Pryor B, Bologna AG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482

    Article  PubMed  CAS  Google Scholar 

  27. Cansu DU, Kalifoglu T, Korkmaz C (2008) Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis. J Rheumatol 35(3):421–424

    PubMed  CAS  Google Scholar 

  28. Cheney CP, Chopra S, Graham C (2000) Hepatis C. Infect Dis Clin North Am 14(3):633–667

    Article  PubMed  CAS  Google Scholar 

  29. Silini E, Locasciulli A, Santoleri L, Gargantini L, Pinzello G, Montillo M et al (2002) Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 87(11):1200–1208

    PubMed  Google Scholar 

  30. Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M et al (1995) Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345(8950):603–607

    Article  PubMed  CAS  Google Scholar 

  31. Knoll A, Helmig M, Peters O, Jilg W (2001) Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 81(3):251–262

    Article  PubMed  CAS  Google Scholar 

  32. Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P et al (2008) Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627–633

    Article  PubMed  Google Scholar 

  33. Ross RS, Viazov S, Khudyakov YE, Xia GL, Lin Y, Holzmann H et al (2009) Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol 81(2):249–257

    Article  PubMed  CAS  Google Scholar 

  34. Steeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35–S46

    Google Scholar 

  35. Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiessch J, de Sousa PS, Ginuino CF, Paranhos-Baccala G et al (2010) Prospective follow-up of patients with acute hepatitis C virus infection in Brazil. Clin Infect Dis 50(9):1222–1230

    Article  PubMed  CAS  Google Scholar 

  36. Maillefert JF, Muller G, Falgarone G, Bour JB, Ratovohery D, Dougados M et al (2002) Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):635–637

    Article  PubMed  CAS  Google Scholar 

  37. Palazzi C, D’Amico E, D’Angelo S, Nucera A, Petricca A, Olivieri I (2008) Hepatitis C virus infection in Italian patients with fibromyalgia. Clin Rheumatol 27(1):101–103

    Article  PubMed  CAS  Google Scholar 

  38. Abu shakra M, El-Sana S, Margalith M, Silkuler E, Neumann L, Buskila D (1997) Hepatitis B and C viruses serology in patients with SLE. Lupus 6(6):543–544

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Cairo, Egypt

    Ayman El Garf, Bassel El Zorkany, Rasha Gheith, Geilan Abdel Moneim & Kamal El Garf

  2. Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt

    Hala Sheba

  3. 45 Dokki Street, Dokki Square, Giza, 12311, Egypt

    Ayman El Garf

Authors
  1. Ayman El Garf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bassel El Zorkany
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rasha Gheith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hala Sheba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Geilan Abdel Moneim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kamal El Garf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayman El Garf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El Garf, A., El Zorkany, B., Gheith, R. et al. Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward. Rheumatol Int 32, 2691–2695 (2012). https://doi.org/10.1007/s00296-011-2014-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2014-8

Keywords

Search

Navigation